← Every insider

Francisco Partners Iv, L.P.

10% owner. Files against GDRX. Everything below is filed with the SEC within two business days of the trade. Filed as FRANCISCO PARTNERS IV, L.P..

Filed lines
20
2026-08-19 to 2026-08-26
Bought
—
open market
Sold
$9.7M
open market
Net
$9.7M
sold more

Every reported line

Purchases, sales, grants, option exercises and shares withheld for tax.

CompanyActionValue
GDRXGoodRx Holdings Inc2026-08-26
Sale
$749.6K
GDRXGoodRx Holdings Inc2026-08-26
Sale
$1.5M
GDRXGoodRx Holdings Inc2026-08-26
Sale
$1.5M
GDRXGoodRx Holdings Inc2026-08-26
Sale
$739K
GDRXGoodRx Holdings Inc2026-08-25
Sale
$220.8K
GDRXGoodRx Holdings Inc2026-08-25
Sale
$217.7K
GDRXGoodRx Holdings Inc2026-08-24
Sale
$246.8K
GDRXGoodRx Holdings Inc2026-08-24
Sale
$250.3K
GDRXGoodRx Holdings Inc2026-08-21
Sale
$483.7K
GDRXGoodRx Holdings Inc2026-08-21
Sale
$476.9K
GDRXGoodRx Holdings Inc2026-08-20
Sale
$821.7K
GDRXGoodRx Holdings Inc2026-08-20
Sale
$752.8K
GDRXGoodRx Holdings Inc2026-08-19
Conversionderivative
—
GDRXGoodRx Holdings Inc2026-08-19
Conversion
—
GDRXGoodRx Holdings Inc2026-08-19
Conversion
—
GDRXGoodRx Holdings Inc2026-08-19
J
—
GDRXGoodRx Holdings Inc2026-08-19
J
—
GDRXGoodRx Holdings Inc2026-08-19
Sale
$839K
GDRXGoodRx Holdings Inc2026-08-19
Sale
$827.1K
GDRXGoodRx Holdings Inc2026-08-19
Conversionderivative
—

Source: SEC Form 4 and Form 144 filings, via EDGAR. Form 144 carries no filer identifier, so those notices are matched to this page by name alone. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.

Follow Francisco Partners Iv, L.P. by email

Francisco Partners Iv, L.P.'s new Form 4 trades, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.

Related datasets